A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor
Clinical trial NCT06166472 · UNKNOWN
Trial details
- NCT number
- NCT06166472
- Sponsor
- Akeso
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2026-04-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.